Pegcetacoplan

CHICAGO — In this video, Clement K. Chan, MD, FACS, discusses highlights from the AAO meeting, including presentations on pegcetacoplan and avacincaptad pegol for the treatment of geographic atrophy.

CHICAGO — In this video, Clement K. Chan, MD, FACS, recaps a lecture from the Macula Society symposium at the AAO meeting.

CHICAGO —In this video, Karl G. Csaky, MD, PhD, highlights discussions from the AAO meeting on the adequacy of tools used to assess the effectiveness of treatments for dry age-related macular degeneration.

CHICAGO — In this video, Karl G. Csaky, MD, PhD, discusses highlights from the AAO annual meeting.

CHICAGO — In this video, Joan W. Miller, MD, chair of ophthalmology at Mass Eye and Ear, discusses study results presented at the AAO meeting on ONL1204 from ONL Therapeutics.

CHICAGO — In this video, Joan W. Miller, MD, chair of ophthalmology at Mass Eye and Ear, discusses controversies surrounding the use of complement inhibitors for the treatment of geographic atrophy.

SAN DIEGO — Pegcetacoplan may offer a clinical strategy to stabilize kidney function and reduce proteinuria significantly for patients with C3 glomerulopathy or primary immune complex membranoproliferative glomerulonephritis, data show.

CHICAGO — In this video, Joan W. Miller, MD, chair of ophthalmology at Mass Eye and Ear, discusses highlights from the AAO meeting.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Baruch D. Kuppermann, MD, PhD, comments on the decision of the European Medicines Agency to reject the appeal for the approval of pegcetacoplan.

BARCELONA, Spain — In this Healio Video Perspective, Jean-François Korobelnik, MD, PhD, discusses the decision of the European Medicines Agency to reject marketing authorization of pegcetacoplan in Europe.